Viewing Study NCT04793958


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2025-12-25 @ 9:59 PM
Study NCT ID: NCT04793958
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-11
First Post: 2021-03-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Sponsor: Mirati Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module